EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

Comparison of intraocular pressure elevation following intravitreal injection of 70 µl aflibercept 8 mg

Xien Lu, Keiko Kataoka, Mariko Kumagai, Yuta Nochi, Akiko Yamamoto, Rie Ko, Annabelle A Okada

Japanese Journal of Ophthalmology · 2025

DOI: 10.1007/s10384-025-01239-7 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Japanese Journal of Ophthalmology, 2025. Verfasst von Xien Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-shi, Tokyo, Japan. Hauptthemen laut MEDLINE: Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Intraocular Pressure, Ocular Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess the effect of increased injection volume on intraocular pressure (IOP) following intravitreal injections of aflibercept 8 mg (70 µl) compared to conventional anti-vascular endothelial growth factor drugs. STUDY DESIGN: Retrospective observational study METHODS: This retrospective observational study included eyes treated with 50 µl of either aflibercept 2 mg or faricimab 6 mg, followed by a switch to 70 µl of aflibercept 8 mg. IOP was measured before and 30 minutes after intravitreal injections. IOP changes in treated and fellow eyes were analyzed, with potential associations examined between IOP changes and clinical parameters. RESULTS: A total of 88 eyes from 85 patients were switched to aflibercept 8 mg during the study period. Due to incomplete data, 17 eyes from 15 patients were excluded, leaving 71 eyes from 70 patients for the analysis. IOP significantly increased from 13.2 ± 2.9 mmHg to 19.1± 5.4 mmHg (P< 0.001) with 50 µl injections and from 13.3 ± 2.9 mmHg to 19.8 ± 4.8 mmHg (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsIntraocular PressureOcular HypertensionHumansIntravitreal InjectionsRetrospective StudiesMaleFemaleAgedMiddle AgedAngiogenesis InhibitorsFollow-Up StudiesVascular Endothelial Growth Factor AVisual AcuityTonometry, OcularAged, 80 and overDose-Response Relationship, Drug

Stichwörter der Autor:innen

Aflibercept 8 mgIntraocular pressureNeovascular age-related macular degeneration

Substanzen

afliberceptReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsAngiogenesis InhibitorsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-shi, Tokyo, Japan.
  • Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-shi, Tokyo, Japan. keiko-kataoka@ks.kyorin-u.ac.jp.
  • Department of Ophthalmology, Juntendo University Faculty of Medicne, Tokyo, Japan.

Zitieren

APA

Lu, X., Kataoka, K., Kumagai, M., Nochi, Y., Yamamoto, A., Ko, R., & Okada, A. A. (2025). Comparison of intraocular pressure elevation following intravitreal injection of 70 µl aflibercept 8 mg. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-025-01239-7

Vancouver

Lu X, Kataoka K, Kumagai M, Nochi Y, Yamamoto A, Ko R, et al. Comparison of intraocular pressure elevation following intravitreal injection of 70 µl aflibercept 8 mg. Japanese Journal of Ophthalmology. 2025. doi:10.1007/s10384-025-01239-7

BibTeX
@article{Lu2025,
  author = {Lu, Xien and Kataoka, Keiko and Kumagai, Mariko and Nochi, Yuta and Yamamoto, Akiko and Ko, Rie and Okada, Annabelle A},
  title = {Comparison of intraocular pressure elevation following intravitreal injection of 70 µl aflibercept 8 mg},
  journal = {Japanese Journal of Ophthalmology},
  year = {2025},
  doi = {10.1007/s10384-025-01239-7}
}
Kostenlos starten →